1. Home
  2. MIST vs ZTO Comparison

MIST vs ZTO Comparison

Compare MIST & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ZTO
  • Stock Information
  • Founded
  • MIST 2003
  • ZTO 2002
  • Country
  • MIST Canada
  • ZTO China
  • Employees
  • MIST N/A
  • ZTO N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ZTO Advertising
  • Sector
  • MIST Health Care
  • ZTO Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • ZTO Nasdaq
  • Market Cap
  • MIST 164.9M
  • ZTO 15.2B
  • IPO Year
  • MIST N/A
  • ZTO 2016
  • Fundamental
  • Price
  • MIST $1.87
  • ZTO $19.19
  • Analyst Decision
  • MIST Strong Buy
  • ZTO Strong Buy
  • Analyst Count
  • MIST 3
  • ZTO 4
  • Target Price
  • MIST $6.33
  • ZTO $21.90
  • AVG Volume (30 Days)
  • MIST 1.5M
  • ZTO 1.5M
  • Earning Date
  • MIST 11-11-2025
  • ZTO 11-19-2025
  • Dividend Yield
  • MIST N/A
  • ZTO 3.12%
  • EPS Growth
  • MIST N/A
  • ZTO N/A
  • EPS
  • MIST N/A
  • ZTO 1.13
  • Revenue
  • MIST N/A
  • ZTO $6,465,566,040.00
  • Revenue This Year
  • MIST N/A
  • ZTO $11.48
  • Revenue Next Year
  • MIST N/A
  • ZTO $12.42
  • P/E Ratio
  • MIST N/A
  • ZTO $17.04
  • Revenue Growth
  • MIST N/A
  • ZTO 14.70
  • 52 Week Low
  • MIST $0.63
  • ZTO $16.34
  • 52 Week High
  • MIST $2.75
  • ZTO $24.87
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.30
  • ZTO 53.81
  • Support Level
  • MIST $1.85
  • ZTO $18.84
  • Resistance Level
  • MIST $2.14
  • ZTO $19.31
  • Average True Range (ATR)
  • MIST 0.11
  • ZTO 0.40
  • MACD
  • MIST -0.03
  • ZTO 0.04
  • Stochastic Oscillator
  • MIST 5.69
  • ZTO 75.17

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.

Share on Social Networks: